New glasses could help Kids' eyesight stop getting worse
NCT ID NCT05562622
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests whether special spectacle lenses called Diffusion Optics Technology (DOT) lenses can slow the progression of nearsightedness (myopia) in Chinese children aged 6 to 13. Over 12 months, 195 children will wear either the DOT lenses or standard single-vision lenses. The main goal is to see if the DOT lenses reduce the lengthening of the eye, which is linked to worsening myopia.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Diffusion Optics Technology (DOT) spectacle lenses
What this could lead to
If successful, these lenses could offer a simple, non-invasive way to slow the progression of nearsightedness in children, reducing the need for stronger prescriptions over time.
What could go wrong
This is a 12-month study with 195 children, so results are still early. The lenses may not work for everyone, and long-term benefits beyond one year are not yet known.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOPIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aier Eye Hospital
Changsha, China
-
Fudan University EENT
Shanghai, China
-
Tianjin Eye Hospital
Tianjin, China
-
West China Hospital
Chengdu, China
-
Zhongshan Ophthalmic Center
Guangzhou, China